Skip to content
Disclosery

EXANE DERIVATIVES: MSFT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MSFT, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 24,041 MSFT shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 24,041 shares
    Change vs previous 13F -3,983 shares

    3.55% of the 13F portfolio, value $6,173,089.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 28,024 shares
    Change vs previous 13F +479 shares

    2.43% of the 13F portfolio, value $8,639,429.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 27,545 shares
    Change vs previous 13F -9,338 shares

    2.25% of the 13F portfolio, value $9,263,472.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 36,883 shares
    Change vs previous 13F -2,335 shares

    2.59% of the 13F portfolio, value $10,397,540.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 39,218 shares
    Change vs previous 13F +2,782 shares

    2.58% of the 13F portfolio, value $11,019,131.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 36,436 shares
    Change vs previous 13F +2,960 shares

    2.59% of the 13F portfolio, value $8,589,994.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 33,476 shares
    Change vs previous 13F +745 shares

    2.26% of the 13F portfolio, value $7,445,265.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 32,731 shares
    Change vs previous 13F not available

    2.24% of the 13F portfolio, value $6,884,025.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).